Environmental Chemical Contribution to the Modulation of Bile Acid Homeostasis and Farnesoid X Receptor Signaling

被引:7
|
作者
Taylor, Rulaiha E. [1 ]
Bhattacharya, Anisha [1 ]
Guo, Grace L. [1 ,2 ,3 ,4 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmacol & Toxicol, Piscataway, NJ USA
[2] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ USA
[3] Rutgers State Univ, Rutgers Ctr Lipid Res, Piscataway, NJ USA
[4] VA New Jersey Hlth Care Syst, Vet Adm Med Ctr, E Orange, NJ USA
基金
美国国家卫生研究院;
关键词
ARYL-HYDROCARBON RECEPTOR; FATTY LIVER-DISEASE; BREAST-CANCER RISK; NONALCOHOLIC STEATOHEPATITIS; ORGANOCHLORINE PESTICIDES; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; PERFLUOROALKYL SULFONATES; ENDOGENOUS BIOMARKERS; EXPRESSION CLONING; OBETICHOLIC ACID;
D O I
10.1124/dmd.121.000388
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Maintaining bile acid (BA) homeostasis is important and regulated by BA activated receptors and signaling pathways. Farnesoid X receptor (FXR) and its regulated target networks in both the liver and the intestines are critical in suppressing BA synthesis and promoting BA transport and enterohepatic circulation. In addition, FXR is critical in regulating lipid metabolism and reducing inflammation, processes critical in the development of cholestasis and fatty liver diseases. BAs are modulated by, but also control, gut microflora. Environmental chemical exposure could affect liver disease development. However, the effects and the mechanisms by which environmental chemicals interact with FXR to affect BA homeostasis are only emerging. In this minireview, our focus is to provide evidence from reports that determine the effects of environmental or therapeutic exposure on altering homeostasis and functions of BAs and FXR. Understanding these effects will help to determine liver disease pathogenesis and provide better prevention and treatment in the future. SIGNIFICANCE STATEMENT Environmental chemical exposure significantly contributes to the development of cholestasis and nonalcoholic steatohepatitis (NASH). The impact of exposures on bile acid (BA) signaling and Farnesoid X receptor-mediated gut-liver crosstalk is emerging. However, there is still a huge gap in understanding how these chemicals contribute to the dysregulation of BA homeostasis and how this dysregulation may promote NASH development.
引用
收藏
页码:456 / 467
页数:12
相关论文
共 50 条
  • [21] Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism
    Pathak, Preeti
    Liu, Hailiang
    Boehme, Shannon
    Xie, Cen
    Krausz, Kristopher W.
    Gonzalez, Frank
    Chiang, John Y. L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (26) : 11055 - 11069
  • [22] FARNESOID X RECEPTOR: ACTING THROUGH BILE ACIDS TO TREAT METABOLIC DISORDERS
    Zhang, Y.
    DRUGS OF THE FUTURE, 2010, 35 (08) : 635 - 641
  • [23] Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice
    Xu, Yang
    Li, Fei
    Zalzala, Munaf
    Xu, Jiesi
    Gonzalez, Frank J.
    Adorini, Luciano
    Lee, Yoon-Kwang
    Yin, Liya
    Zhang, Yanqiao
    HEPATOLOGY, 2016, 64 (04) : 1072 - 1085
  • [24] The Hypoglycemic Effect of Berberine and Berberrubine Involves Modulation of Intestinal Farnesoid X Receptor Signaling Pathway and Inhibition of Hepatic Gluconeogenesis
    Sun, Runbin
    Kong, Bo
    Yang, Na
    Cao, Bei
    Feng, Dong
    Yu, Xiaoyi
    Ge, Chun
    Feng, Siqi
    Fei, Fei
    Huang, Jingqiu
    Lu, Zhenyao
    Xie, Yuan
    Yang, Chung S.
    Guo, Grace L.
    Wang, Guangji
    Aa, Jiye
    DRUG METABOLISM AND DISPOSITION, 2021, 49 (03) : 276 - 286
  • [25] Process Research and Impurity Control Strategy for Obeticholic Acid, a Farnesoid X Receptor Agonist
    Feng, Wei-Dong
    Zhuo, Song-Ming
    Zhang, Fu-Li
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2019, 23 (09) : 1979 - 1989
  • [26] Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-κB Signaling, and Hepatic Inflammation
    Gai, Zhibo
    Visentin, Michele
    Gui, Ting
    Zhao, Lin
    Thasler, Wolfgang E.
    Haeusler, Stephanie
    Hartling, Ivan
    Cremonesi, Alessio
    Hiller, Christian
    Kullak-Ublick, Gerd A.
    MOLECULAR PHARMACOLOGY, 2018, 94 (02) : 802 - 811
  • [27] Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis
    Wang, Hong
    Ge, Chaoliang
    Zhou, Jiyu
    Guo, Yitong
    Cui, Shuang
    Huang, Ningning
    Yan, Tingting
    Cao, Lijuan
    Che, Yuan
    Zheng, Qiuling
    Zheng, Xiao
    Gonzalez, Frank J.
    Wang, Guangji
    Hao, Haiping
    EBIOMEDICINE, 2018, 37 : 322 - 333
  • [28] Investigation on bile acid receptor regulators. Discovery of cholanoic acid derivatives with dual G-protein coupled bile acid receptor 1 (GPBAR1) antagonistic and farnesoid X receptor (FXR) modulatory activity
    Sepe, Valentina
    Renga, Barbara
    Festa, Carmen
    Finamore, Claudia
    Masullo, Dario
    Carino, Adriana
    Cipriani, Sabrina
    Distrutti, Eleonora
    Fiorucci, Stefano
    Zampella, Angela
    STEROIDS, 2016, 105 : 59 - 67
  • [29] Natural Products in the Modulation of Farnesoid X Receptor Against Nonalcoholic Fatty Liver Disease
    Wang, Jing
    Yang, Na
    Xu, Yu
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2024, 52 (02): : 291 - 314
  • [30] Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis
    Li, Hongshan
    Xi, Yingfei
    Xin, Xin
    Tian, Huajie
    Hu, Yiyang
    NUTRITION & METABOLISM, 2020, 17 (01)